Yuji Uehara, Medical Oncologist at the National Cancer Center of Japan, shared a post on X:
“Proud to co-author our JTO review on MET in EGFRm NSCLC!
Thanks Stephanie Saw for leading. Global work with wonderful friends Molly Li, Hiroto Hatano and mentors Mariana Brandao, Jordi Remon, Lizza Hendriks is why I stay in academia! ”
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared this post, adding:
“Our review on targeting MET in EGFRm NSCLC is out in JTO!
Always interesting to appreciate the similar challenges we face treating EGFRm lung cancer around the world. Thanks to all my co-authors, academia is much better with friends indeed”
Title: Targeting MET in EGFR-mutated NSCLC
Authors: Stephanie P.L. Saw, Molly S.C. Li, Sehhoon Park, Hiroto Hatano, Yuji Uehara, Jessica Menis, Mariana Brandão, Lizza E.L. Hendriks, Jordi Remon
Read the Full Article.
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: What the New IASLC Consensus Means
